Inventor
BRANCHEK THERESA
US43 patents
⚠️ This page may combine multiple inventors who share the name “BRANCHEK THERESA”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
SYNAPTIC PHARMA CORP
36 patentsUS5360735ANov 1, 1994
DNA encoding a human 5-HT1F receptor, vectors, and host cells
SYNAPTIC PHARMA CORP98 citations97
US5989920ANov 23, 1999
Methods of modifying feeding behavior compounds useful in such methods and DNA encoding a hypothalmic atypical neuropeptide Y/peptide YY receptor Y5
SYNAPTIC PHARMA CORP51 citations96
US5968819AOct 19, 1999
DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP38 citations96
US5602024AFeb 11, 1997
DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5) and uses thereof
SYNAPTIC PHARMA CORP60 citations96
US5516653AMay 14, 1996
DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
SYNAPTIC PHARMA CORP31 citations96
US5661024AAug 26, 1997
DNA encoding a human serotonic (5-HT2) receptor and uses thereof
SYNAPTIC PHARMA CORP91 citations95
US5545549AAug 13, 1996
DNA encoding a human neuropeptide Y/peptide YY (Y2) receptor and uses thereof
SYNAPTIC PHARMA CORP35 citations95
US6420532B1Jul 16, 2002
Method of obtaining compositions comprising Y2 specific compounds
SYNAPTIC PHARMA CORP31 citations92
US6383762B1May 7, 2002
Methods of obtaining compounds that interact with a human serotonin (5-HT2) receptor
SYNAPTIC PHARMA CORP36 citations92
US6331401B1Dec 18, 2001
Uses of the 5-HT4 receptor
SYNAPTIC PHARMA CORP30 citations92
US6316203B1Nov 13, 2001
Methods of screening and preparing a composition using DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP28 citations92
US5989834ANov 23, 1999
Uses of nucleic acid encoding neuropeptide Y/peptide YY (Y2) receptors nucleic acid encoding
SYNAPTIC PHARMA CORP19 citations92
US5935925AAug 10, 1999
Methods of treating migraine and compounds useful for such methods
SYNAPTIC PHARMA CORP23 citations92
US5885785AMar 23, 1999
DNA encoding a human serotonin (5-HT2) receptor and uses thereof
SYNAPTIC PHARMA CORP35 citations92
US5766879AJun 16, 1998
DNA encoding 5-HT4 serotonin receptors and uses thereof
SYNAPTIC PHARMA CORP18 citations92
US5972624AOct 26, 1999
Method of identifying ligands which bind recombinant galanin receptor (GALR2)
SYNAPTIC PHARMA CORP32 citations91
US6645774B1Nov 11, 2003
Methods of modifying feeding behavior using compounds with afinity for the human hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP13 citations84
US5476782ADec 19, 1995
DNA encoding a human 5-HT1E receptor and uses thereof
SYNAPTIC PHARMA CORP15 citations82
US5976814ANov 2, 1999
DNA encoding a human neuropeptide Y/peptide YY/pancreatic polypeptide receptor (Y4) and uses thereof
SYNAPTIC PHARMA CORP9 citations74
US5786155AJul 28, 1998
Methods for identifying a compound that binds to a human 5-HT 1E receptor
SYNAPTIC PHARMA CORP5 citations74
US5652113AJul 29, 1997
DNA encoding a human 5-HT 1F receptor and uses thereof
SYNAPTIC PHARMA CORP6 citations74
US5639652AJun 17, 1997
DNA encoding a human 5-HT1F receptor and uses thereof
SYNAPTIC PHARMA CORP4 citations74
US6586191B2Jul 1, 2003
Method of identifying compounds that bind galanin receptor (GALR2)
SYNAPTIC PHARMA CORP4 citations72
US6818445B2Nov 16, 2004
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP2 citations63
US6475746B1Nov 5, 2002
Method of obtaining a composition comprising a 5-HT1D selective compound
SYNAPTIC PHARMA CORP1 citations63
US6406859B1Jun 18, 2002
DNA encoding a 5-HT 1F receptor and uses thereof
SYNAPTIC PHARMA CORP2 citations63
US6376243B1Apr 23, 2002
DNA encoding a human serotonin receptor (5-HT4b) and uses thereof
SYNAPTIC PHARMA CORP2 citations63
US6300087B1Oct 9, 2001
DNA encoding a human serotonin receptor (5-HT4B) and uses thereof
SYNAPTIC PHARMA CORP4 citations63
US6096507AAug 1, 2000
Methods for identifying a compound that binds to a human 5-HT1E receptor
SYNAPTIC PHARMA CORP3 citations63
US6083749AJul 4, 2000
DNA encoding a human serotonin receptor (5-HT4B) and uses thereof
SYNAPTIC PHARMA CORP2 citations63
US5958709ASep 28, 1999
Processes for identifying compounds that bind to the human Y4 receptor
SYNAPTIC PHARMA CORP1 citations63
US6127131AOct 3, 2000
DNA encoding a glycine transporter and uses thereof
SYNAPTIC PHARMA CORP2 citations62
US5756348AMay 26, 1998
DNA encoding a glycine transporter and uses thereof
SYNAPTIC PHARMA CORP5 citations62
US6790656B1Sep 14, 2004
DNA encoding galanin GALR2 receptors
SYNAPTIC PHARMA CORP1 citations61
US6713265B1Mar 30, 2004
Methods of modifying feeding behavior, compounds useful in such methods, and DNA encoding a hypothalamic atypical neuropeptide Y/peptide YY receptor (Y5)
SYNAPTIC PHARMA CORP1 citations52
US6432655B1Aug 13, 2002
Method of obtaining compositions
SYNAPTIC PHARMA CORP0 citations52
LUNDBECK & CO AS H
3 patentsUS6913892B1Jul 5, 2005
Method of obtaining compositions comprising Y4 specific compounds
LUNDBECK & CO AS H4 citations74
US7132248B2Nov 7, 2006
Uses of galanin GALR2 receptors
LUNDBECK & CO AS H0 citations51
US7060449B2Jun 13, 2006
Method of preparing GALR2 receptors composition
LUNDBECK & CO AS H0 citations51